#IMGS-203
LightNews LightNews
newsen.bsky.social
ImmunoGenesis Unveils Breakthrough Publications Advocating IMGS-203 Against Tumor Immune Resistance#USA#Houston#ImmunoGenesis#STING_Agonist#IMGS-203
ImmunoGenesis Unveils Breakthrough Publications Advocating IMGS-203 Against Tumor Immune Resistance
ImmunoGenesis has announced significant findings regarding IMGS-203, a novel STING agonist. These studies can enhance antitumor efficacy in brain cancer treatments.
third-news.com
November 5, 2026 at 5:35 PM
newsen.bsky.social
ImmunoGenesis to Showcase IMGS-203 Progress at SITC 2026 Annual Meeting#United_States#Glioblastoma#Phoenix,_AZ#ImmunoGenesis#IMGS-203
ImmunoGenesis to Showcase IMGS-203 Progress at SITC 2026 Annual Meeting
ImmunoGenesis is set to present their innovative immunotherapy, IMGS-203, at the SITC 2026 Annual Meeting, highlighting its promise in treating glioblastoma.
third-news.com
November 4, 2026 at 6:57 PM
ninpatentswatch.bsky.social
2a. Close to 30% of all patents filed or issued are continuations/divisions based on a parent patent (imgs 1-4). They are very common, including the 3 patents in the lawsuit, but GF again reframed them as anticompetitive.

2b. Patent infringement is determined by the parent patent’s filing date …
Economics of Innovation and New Technology, Volume 13, 2004 https://www.tandfonline.com/doi/abs/10.1080/1043859042000188700 Submarines in software? continuations in US software patenting in the 1980s and 1990s Stuart J. H. Graham & David C. Mowrey Figure 1 Continuation patents as a share of issued patents, software patents compared with all other patents, 1987–1999. https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf 17 Yale Journal of Law and Technology 203 (2015) WHAT IS THE PROBABILITY OF RECEIVING A U.S. PATENT? Michael Carley, Deepak Hegde, and Alan Marco Table A2: Progenitor Applications and Related Continuation Applications, 1996-2005 Table A2 shows the number of progenitor applications filed per year and the percentage of progenitor applications from each cohort that resulted in continuations. https://patentlyo.com/patent/2015/09/empirical-popularity-prosecution.html Patently-O, September 27, 2015 To File a CON? Empirical Popularity and Prosecution Outcomes Jason Rantanen, Professor, University of Iowa College of Law Overall, in fiscal year 2015, 20% of the filed applications were continuation applications. Divisionals comprised 6% of the data set, and continuation-in-part applications accounted for 3% of the applications. The remaining 72% lacked a priority claim to another non-provisional U.S. application. https://www.sciencedirect.com/science/article/pii/S0048733323000264 Research Policy, Volume 52, Issue 4, May 2023 Continuing patent applications at the USPTO Cesare Righi, Davide Cannito, Theodor Vladasel Fig. 1. Patents from continuing applications by filing year. Panel B plots the percentage of patents that issue from continuing application by filing year. The sample contains patents granted between 1981 and 2020, filed between 1981 and 2016. We exclude reissues.
June 23, 2026 at 11:26 PM
ninpatentswatch.bsky.social
[Pokémon patent disinformation, thread 2 of 3]
Games Fray’s half-truths, falsehoods, and gaslighting:

1a. ~85% of patent applications are temporarily rejected (imgs 1-3). It’s basically dog-bites-man, and yet GF shouted from the rooftops whenever that occurred, to insinuate impropriety …
17 Yale Journal of Law and Technology 203 (2015) https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf WHAT IS THE PROBABILITY OF RECEIVING A U.S. PATENT? Michael Carley, Deepak Hegde, and Alan Marco Figure 1 shows a simplified representation of the U.S. patent examination process. It also shows the key intermediate and final outcomes, as of June 30, 2013, for the 2.15 million applications filed for the first time (“progenitor” applications) between 1996 and 2005. The percentage indicated at each transition state reflects the percentage of the total progenitor applications that reached the state. First-action allowance rate refers to the proportion of progenitor applications that were allowed without amendment 11.4% Journal of Economic Perspectives—Volume 27, Number 1—Winter 2013 https://pubs.aeaweb.org/doi/pdfplus/10.1257/jep.27.1.67 Of Smart Phone Wars and Software Patents Stuart Graham and Saurabh Vishnubhakat Figure 2 Share of US Patent Office First Actions that Were Allowances, FY 2003–FY 2012 Software ~13% Non software ~14% Patently-O, June 17, 2026 https://patentlyo.com/patent/2026/06/the-first-offer-accepted-first-action-allowances-and-the-track-1-premium.html#more-48801 The First Offer Accepted: First-Action Allowances and the Track 1 Premium Dennis Crouch, Professor, University of Missouri School of Law For this post I look at first actions over the past couple of decades — measuring two things: how long applicants waited for the first action, and how often the first action was a Notice of Allowance rather than a rejection. The share of first action allowances fell from about 17% in early 2004 to roughly 7% during 2008 and 2009, then recovered slowly to 15% range by the late 2010s, where it sits today.
June 23, 2026 at 11:26 PM
l2plabs.bsky.social
ImmunoGenesis Announces Poster Presentation at AACR 2026 Annual Meeting
Presentation details the IND-enabling work for IMGS-203, a potent Stimulator of Interferon Genes (STING) Agonist, for the treatment of Glioblastoma Multiforme (GBM) HOUSTON, April 15, 2026 /PRNewswire/ -- ImmunoGenesis, a clinical-stage biotech company developing innovative,...
dlvr.it
April 15, 2026 at 12:02 PM